NJ Plavix Suit Stayed Pending Supreme Court FCA Ruling
A New Jersey federal judge on Wednesday paused a False Claims Act accusing Sanofi-Aventis US LLC and Bristol-Myers Squibb Co. of deceptively pushing the blood thinner Plavix, pending a U.S. Supreme...To view the full article, register now.
Already a subscriber? Click here to view full article